TransAct Technologies Inc (TACT) stock
Close on Nov 13, 2026Market cap $50.07MP/E –Yield –
Earnings
TransAct Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of TransAct Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 9, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026after the close | $14.40M | +9.1% | -$0.04 | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 11, 2026during market hours | $13.90M | +0.7% | $0.00 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026during market hours | $14.40M | +9.9% | $0.07 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 10, 2026during market hours | $11.50M | +12.7% | -$0.11 | -$0.11 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 10, 2025during market hours | $13.20M | +21.1% | $0.00 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025during market hours | $13.80M | +19.0% | -$0.01 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025during market hours | $13.10M | +22.4% | $0.00 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 13, 2025during market hours | $10.20M | -23.3% | -$0.79 | -$0.06 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024during market hours | $10.90M | -36.6% | -$0.06 | -$0.06 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024during market hours | $11.60M | -41.7% | -$0.03 | -$0.03 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024before the open | $10.70M | -52.0% | -$0.10 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 12, 2024during market hours | $13.30M | -26.1% | -$0.01 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023during market hours | $17.20M | -3.9% | $0.09 | $0.09 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023during market hours | $19.90M | +57.9% | $0.08 | $0.22 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023during market hours | $22.30M | +129.9% | $0.31 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 8, 2023during market hours | $18.00M | +62.2% | $0.03 | $0.03 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022during market hours | $17.90M | +68.9% | $0.05 | $0.05 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 17, 2022during market hours | $12.60M | – | -$0.24 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022during market hours | $9.70M | – | -$0.41 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 9, 2022during market hours | $11.10M | – | -$0.07 | -$0.19 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021during market hours | $10.60M | – | $0.09 | -$0.13 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 9, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 6, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
TransAct Technologies's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net salesGAAP | FY2026 | $55.00M – $56.00M | – | New | Nov 12, 2026 |
| net sales | FY2026 | $55.00M – $57.00M | $55.00M – $57.00M | Reaffirmed | Aug 11, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $1.50M – $1.75M | – | New | Nov 12, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $1.50M – $2.00M | $1.00M – $1.75M | Raised | Aug 11, 2026 |
Guidance vs results
The last range TransAct Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $50.00M – $53.00M | $51.60MΣ4Q | Within range |
Guidance history
Every forecast TransAct Technologies put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 12, 2026 | adjusted EBITDA | FY2026 | $1.50M – $1.75M | New |
| Nov 12, 2026 | net sales | FY2026 | $55.00M – $56.00M | New |
| Aug 11, 2026 | adjusted EBITDA | FY2026 | $1.50M – $2.00M | Raised |
| Aug 11, 2026 | net sales | FY2026 | $55.00M – $57.00M | Reaffirmed |
| May 12, 2026 | adjusted EBITDA | FY2026 | $1.00M – $1.75M | Raised |
| May 12, 2026 | net sales | FY2026 | $55.00M – $57.00M | Reaffirmed |
| Mar 10, 2026 | adjusted EBITDA | FY2026 | $800.00K – $1.50K | New |
| Mar 10, 2026 | net sales | FY2026 | $55.00M – $57.00M | New |
| Nov 10, 2025 | adjusted EBITDA | FY2025 | $0 – $1.50M | New |
| Nov 10, 2025 | Net Sales | FY2025 | $50.00M – $53.00M | New |
| Aug 6, 2025 | Adjusted EBITDA | FY2025 | $0 – $1.50M | Raised |
| Aug 6, 2025 | Net Sales | FY2025 | $49.00M – $53.00M | Raised |
| May 13, 2025 | adjusted EBITDA | FY2025 | -$1.50M – $0 | Raised |
| May 13, 2025 | Net Sales | FY2025 | $47.00M – $52.00M | Reaffirmed |
| Mar 13, 2025 | Adjusted EBITDA | FY2025 | -$2.00M – $0 | New |
| Mar 13, 2025 | Net Sales | FY2025 | $47.00M – $52.00M | New |
| Nov 7, 2024 | adjusted EBITDA | FY2024 | -$1.00M – -$2.00M | Narrowed |
| Nov 7, 2024 | net sales | FY2024 | $43.00M – $45.00M | Lowered |
| Aug 8, 2024 | Total Adjusted EBITDA | FY2024 | -$2.00M – -$1.00M | Raised |
| Aug 8, 2024 | Total Net Sales | FY2024 | $45.00M – $50.00M | Reaffirmed |
| May 7, 2024 | total adjusted EBITDA | FY2024 | -$3.50M – -$2.50M | New |
| May 7, 2024 | total net sales | FY2024 | $45.00M – $50.00M | New |
| Mar 12, 2024 | Total Net Sales | FY2024 | $53.00M – $58.00M | New |
| Nov 9, 2023 | Total Adjusted EBITDA | FY2023 | $9.50M – $10.00M | Raised |
| Nov 9, 2023 | Total Net Sales | FY2023 | $72.50M – $73.50M | Raised |
| Aug 9, 2023 | total adjusted EBITDA | FY2023 | $8.00M – $8.50M | Raised |
| Aug 9, 2023 | total net sales | FY2023 | $71.50M – $73.50M | Reaffirmed |
| May 9, 2023 | Total Adjusted EBITDA | FY2023 | $6.50M – $7.50M | Raised |
| May 9, 2023 | Total Net Sales | FY2023 | $71.50M – $73.50M | Raised |
| Mar 8, 2023 | Total Adjusted EBITDA | FY2023 | $5.20M – $5.40M | New |
| Mar 8, 2023 | Total Revenue | FY2023 | $70.00M – $72.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases TransAct Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?